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Synchrotron microbeam irradiation 
induces neutrophil infiltration, 
thrombocyte attachment and 
selective vascular damage in vivo
Daniel Brönnimann1,*, Audrey Bouchet1,*,†, Christoph Schneider2, Marine Potez1, 
Raphaël Serduc3, Elke Bräuer-Krisch4, Werner Graber1, Stephan von Gunten2, 
Jean Albert Laissue1 & Valentin Djonov1
Our goal was the visualizing the vascular damage and acute inflammatory response to micro- and 
minibeam irradiation in vivo. Microbeam (MRT) and minibeam radiation therapies (MBRT) are tumor 
treatment approaches of potential clinical relevance, both consisting of parallel X-ray beams and 
allowing the delivery of thousands of Grays within tumors. We compared the effects of microbeams (25–
100 μm wide) and minibeams (200–800 μm wide) on vasculature, inflammation and surrounding tissue 
changes during zebrafish caudal fin regeneration in vivo. Microbeam irradiation triggered an acute 
inflammatory response restricted to the regenerating tissue. Six hours post irradiation (6 hpi), it was 
infiltrated by neutrophils and fli1a+ thrombocytes adhered to the cell wall locally in the beam path. The 
mature tissue was not affected by microbeam irradiation. In contrast, minibeam irradiation efficiently 
damaged the immature tissue at 6 hpi and damaged both the mature and immature tissue at 48 hpi. We 
demonstrate that vascular damage, inflammatory processes and cellular toxicity depend on the beam 
width and the stage of tissue maturation. Minibeam irradiation did not differentiate between mature 
and immature tissue. In contrast, all irradiation-induced effects of the microbeams were restricted to 
the rapidly growing immature tissue, indicating that microbeam irradiation could be a promising tumor 
treatment tool.
The major challenge of treating cancer is to achieve high treatment efficacy within the tumor while reducing col-
lateral damage to the normal tissue. Synchrotron radiation therapy is a new tumor treatment strategy used at the 
preclinical stage1. Microbeam radiation therapy (MRT) is based on the fractionation into arrays of parallel beams, 
thus generating a spatially and periodically alternating dose distribution in the target. The normal tissue shows 
a remarkably high resistance when irradiated with microbeam peak doses up to 5000 Gray (Gy)2. For different 
synchrotron radiation therapies, a variety of beam widths have been proposed. Several variants have emerged 
within the past decades: microbeam radiation therapy3 and minibeam radiation therapy (MBRT), among others4. 
Both MRT and MBRT induced increases in the lifespan of tumor-bearing rodents and are proposed as potential 
tumor therapies2,5–15.
In MRT, 25–100 μ m wide beams, which are typically separated by a few hundred micrometers (Fig. 1A), 
depose in-beam doses of several hundreds of Grays. For example, microbeam doses of 320 to 860 Gy, with a 
center-to-center distance of 200 to 400 μ m, have been applied in several studies10,16, where a significant increase 
in the median survival time for different tumor bearing rodents was achieved. Different mechanisms have been 
proposed to explain the efficiency of MRT in tumor growth control, such as preferential damage on immature 
(tumoral) vessels10, intercellular communication between irradiated and less-irradiated adjacent cells17 or effects 
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on the immune system18,19. The clinical use of MRT is currently limited by the fact that the necessary dose rates 
to apply the treatment without blurring the microbeams during the scan can only be generated by a synchro-
tron6,20–22. Therefore, MBRT was initially proposed as a trade-off to counteract some of the difficulties encoun-
tered with MRT. In MBRT, wider beams (500–700 μ m) and lower doses than in MRT are commonly used21,22 
(Fig. 1A). This procedure is believed to be tolerated by the normal tissue6,21,22. However, studies with a clear focus 
on the tissue sparing effect have not been published yet for MBRT.
In this study, we partially amputated the ventral half of the caudal fin 5–7 days before irradiation (IR) while 
the dorsal half was left untouched. Zebrafish possess a remarkable regenerative potential23 and are able to com-
pletely regrow the caudal fin24. The first week of regeneration is characterized by a rapidly growing, immature 
vascular network, which can be visualized in vivo by the presence of green fluorescent endothelial cells in the 
Tg(fli1a:eGFP)y1 zebrafish25. The fins were then irradiated in the dorsal-ventral axis with a single beam and a 
constant entrance dose of 5000 Gy (Fig. 1B). Single beams of six different widths used in MRT and MBRT were 
applied. The evolution of damage was assessed by in vivo-microscopy (images and movies), light and transmis-
sion electron microscopy. This allowed us to study irradiation-induced effects of micro- and minibeams on both 
mature and immature tissue in terms of blood perfusion, endothelial cell damage and immune response.
Materials and Methods
All procedures related to animal care conformed to the guidelines of the Swiss government and were approved 
by the European Synchrotron Radiation Facility (ESRF) Internal Evaluation Committee for Animal Welfare and 
Rights.
Figure 1. Irradiation of the zebrafish caudal fin. (A) Schematic representation of currently used beam types 
for preclinical radiotherapy studies. (B) Overview of a semi-amputated zebrafish caudal fin. Five to seven 
days post amputation, a single beam with a dose of 5000 Gy and a width of 25, 50, 100, 200, 400 or 800 μ m was 
applied through both mature and immature parts of the fin.
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Study design. The dorsal caudal fin of 41 age-matched Tg(fli1a:egfp)y1 zebrafish (fluorescent endothelial 
cells) were partially amputated25. The fish were divided into seven conditions (control, 25, 50, 100, 200, 400 and 
800 μ m wide beams) and observed at three different time points (6, 48, 96 hpi). Additionally, 72 non-irradiated 
zebrafish were used to study fli1a+ blood cells.
Caudal fin amputation. The ventral half of the caudal fin of fish anesthetized with 0.04% MS-222 (500 μ S, 
pH 7.4) was partially amputated using a scalpel (Fig. 1B) five days before the first set of irradiations.
Synchrotron irradiation. Irradiations were performed at the ID17 biomedical beamline of the ESRF using 
X-rays. The caudal fin of zebrafish was irradiated 6 days after its semi-amputation. The fish were placed perpen-
dicularly to the beam, positioned horizontally in a home-made Plexiglas support. A constant dose of 5000 Gy 
was applied with varying beam widths. The dose rate was ~16,000 Gy.s−1. We chose to apply 5000 Gy after pre-
liminary experiments with 400, 1000 and 2500 Gy and based on the fact that zebrafish26 are up to 10 times more 
radio-resistant than humans27 or rats28.
Dosimetry. The dose rate in MRT under broad beam conditions is determined by measurements using a 
calibrated pinpoint chamber (IC 31014 from PTW, Freiburg, Germany) following a protocol described in detail 
by Bräuer-Krisch et al. and Fournier et al.25. The delivered peak entrance dose is automatically calculated within 
the MRT GUI (Graphical User Interface), which applies Monte Carlo pre-calculated output factors for the differ-
ent beam sizes scaled to the broad beam conditions at 2 cm depth for a 2 cm × 2 cm field size. Experimental dose 
verification with the help of Gafchromic film from ISP (Nuclear Associates) using a modified ZEISS microscope25 
were equally performed.
In vivo-microscopy. Zebrafish were anesthetized using 0.04% MS-222 in system water (500 μ S, pH 7.4) for 
the irradiation procedure and in vivo-microscopy. We used a Leica M205FA stereomicroscope equipped with 
either one of two cameras. A Canon EOS 5D Mark II color camera with the EOS Utility software was used for 
brightfield investigations and movies. A Leica DFC365X grayscale camera with the Leica AF6000 software was 
used for z-stacks, movies and large mosaics.
Flow cytometry, cell labeling and blood smears. For blood withdrawal, 72 non-irradiated zebrafish 
were anesthetized using 0.04% MS-222 in system water. Thereafter, a big portion of their tail was cut using a 
straight razorblade. The emerging blood was collected with a pipette and stored in 100 μ l PBS in heparin-coated 
tubes (Microvette, Sarstedt, DE). For the frequency-assessment of the fli1a+ fraction, the blood was filtered with 
40 μ l cell strainers (Sigma-Aldrich, CH) and data directly acquired using FACSVerse (BD Biosciences). For the 
labeling of different surface cluster of differentiations (CD molecules), the cell isolates were fixed in 2% paraform-
aldehyde for 15 min, washed in PBS with 2% BSA (Sigma-Aldrich) and incubated with primary antibodies for 
20 min at 4 °C. The secondary antibody was applied for 1 h at 4 °C. Stained cells were acquired using FACSVerse 
(BD Biosciences). The rabbit anti-zebrafish monoclonal antibodies against CD4 and CD8 were purchased from 
Anaspec, USA. The secondary donkey anti-rabbit AlexaFluor647-labeled antibody was purchased from Abcam, 
CH. FloJo Version 9.8.1 was used for data analysis. For blood smears, the blood was spread on a glass slide, 
air-dried for 3 min and then observed with a Leica M205FA stereomicroscope to identify fli1a+ cells. Thereafter, 
the cells were immediately stained with Giemsa-May Grünwald (Grogg Chemie, CH).
Co-localization of CD41 and fli1a. Co-localization of CD41 and fli1a was determined in 5 dpf (days post 
fertilization) old fish with a Zeiss LSM880 confocal microscope. Ten pre-screened zebrafish were anesthetized using 
0.04% tricaine and mounted on 35 mm glass-bottom petri dishes (MatTek, USA) using 0.8% agarose. 1000–1500 
pictures of the posterior caudal vein (PCV) were acquired in and manually evaluated using Fiji-ImageJ v1.50 g.
Blood perfusion at the tip of the caudal fin. The caudal fin consists of bony fin rays. Blood perfusion of 
each ray was scored as “yes” if the blood was able to pass the beam path in the artery, flow to the distal tip of the 
fin and back to the trunk. It was scored as “no” if the blood was either not flowing across the beam path (arterial 
damage) or if it was unable to flow back (venous damage). Blood perfusion was mainly assessed directly under 
the microscope, or using recorded movies.
Light and transmission electron microscopy. Right after the in vivo-microscopy, the caudal fins with 
a big portion of the tail of anesthetized fish were cut off and immersed immediately in sodium cacodylate buffer 
(0.1 M, pH 7.4) with 2.5% glutaraldehyde (540 mOsm, pH 7.4), then washed three times for 8 minutes with 0.1 M 
sodium cacodylate buffer (pH 7.4) and post-fixed for 2 hours in the same buffer containing 1% osmium tetrox-
ide (340 mOsm, pH 7.4). After another 3-step washing in the buffer the samples were dehydrated through a 
graded ethanol series and infiltrated with different aceton-epon mixtures. The caudal fins were divided into dor-
sal (mature) and ventral (immature) parts and embedded in epon 812 containing 1.5% accelerator. The samples 
polymerized over 3 days at 60 °C. Semi-thin sections for light microscopy (0.5–1 μ m) and ultra-thin sections 
for TEM (70 nm) were obtained by an UCT Leica ultra-microtome with diamond knives from DIATOME SA. 
Semi-thin sections (0.5–1 μ m) were observed under a light microscope (Zeiss Axio Imager M.2) with a mounted 
Olympus UC50 camera. Ultra-thin sections (70 nm) were observed with a transmission electron microscope 
(Philips TEM400).
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Figure 2. Early cellular response: local adhesion of neutrophils and thrombocytes (A,A’) Stereomicroscopic 
image showing that fli1a+ blood cells adhered to the venous wall inside the beam path (white arrowheads)  
in vivo. (B) Electron micrograph depicting an accumulation of neutrophil (Ne). (C) Scatter plot of peripheral 
blood with back-gated fli1a+ cells (green) clustering in two distinct populations. Red = lymphocytes and 
thrombocytes, blue = precursor cells. (D) Blood smear of untreated zebrafish whole blood. Fli1a+ cells were 
identified by fluorescence microscopy and relocated after staining with Giemsa-May Grünwald. (E) Fraction of 
fli1a+ cells in the whole blood (n = 40 [number of animals]). (F,G) Pseudo-color plots showing the absence of 
fli1a-expression in CD4+ and CD8+ leukocytes. (H) Example of a thrombocyte expressing CD41 and fli1a in 
5 dpf old fish in vivo. (I) Fraction of CD41 and fli1a expressing blood cells in the posterior caudal vein in vivo 
(n = 10 [number of animals]).
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Figure 3. Width-dependent effects of IR on the immature caudal fin vasculature in vivo and as schematic 
representations. Dashed lines depict the beam path. Titles (left grey column) refer to the applied beam width. 
(A–F) Overviews. (G) Non-irradiated vein, 5 days post amputation. (H) 25 μ m-wide beams induced adhesion 
of few fli1a+ thrombocytes in the beam path. (I) 50 μ m-wide beams: adhesion of fli1a+ thrombocytes to the 
venous wall in the beam path. (J) Vein hit by a 100 μ m-wide beam: About 1 μ m sized spots of clumped, intensely 
fluorescent cells. (K) 200 μ m-wide beams: Disrupted arteries and veins. (L) 800 μ m-wide beams induced 
massive cell death inside the beam path. (M–R) Schematic representation of the beamlet width-dependent 
effects integrated from in vivo- (fli1a+ blood cells) and electron microscopy (neutrophils). Black arrows indicate 
the presence or absence (in case the arrow is crossed) of blood flow in arteries or veins. Accumulations of fli1a+ 
thrombocytes and neutrophils are indicated by green and black icons, respectively.
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Statistical analyses. All statistical analyses were performed with GraphPad Prism v5.04. P-values of 
two-tailed paired t-tests were considered statistically significant if p < 0.05 (*p < 0.05, **p < 0.01, ***p < 0.001). 
Values are given as mean ± standard deviation.
Results
Microbeam irradiation leads to an early hemostatic and inflammatory response. We irradiated 
semi-amputated caudal fins of Tg(fli1a:GFP)y1 zebrafish with a single beam of 50 μ m width and a dose of 5000 Gy 
(Fig. 1). Few hours after irradiation (IR), the beam path was visible as a fine line on the caudal fin. Fli1a is labeling 
endothelial cells and a subpopulation of blood cells. At 6 hpi (hours post irradiation), fli1a+ blood cells adhered 
to the endothelium in the beam path of the immature fin (Fig. 2A,A′ ) and continuously attached and detached 
(SI 1). These adherent cells coincided with neutrophils present in TEM micrographs (Fig. 2B). Neutrophils were 
identified by elongated protrusions and their characteristic electron dense, cigar-shaped granules, and were found 
in the blood as well as in the tissue (SI 2). We intraperitoneally injected LPS into adult zebrafish to increase the 
concentration of neutrophils in the blood. Blood smears have shown that these neutrophils did not express fli1a 
(SI 3). Previous research has delineated the different populations of zebrafish blood cells in scatter plots29. By the 
use of flow cytometry, we identified lymphocytes, precursor cells and thrombocytes that fli1a+ cells clustered in 
two different populations in the peripheral blood (Fig. 2C). Taken together, 0.49 ± 0.02% (n = 40 [number of ani-
mals]) of all blood cells were fli1a+ (Fig. 2E). In blood smears, fli1a+ blood cells appeared rounded, considerably 
smaller than the nucleated erythrocytes and with a barely visible amount of cytoplasm, thus suggesting a lympho-
cytic or thrombocytic origin (Fig. 2D). However, fli1a+ cells in the peripheral blood neither expressed CD4, nor 
CD8 (Fig. 2F,G). In a next step, we generated double-transgenic Tg(CD41:GFP, fli1a:RedX) fish and determined 
Figure 4. Effects of micro- (50 μm) and minibeam (800 μm) irradiation on the mature and immature 
vasculature. (A–H) Stereomicroscopic image of the vascular network in vivo at the site of irradiation. At 6 hpi 
(hours post irradiation), the mature vasculature was not affected by any type of irradiation. In contrast to 
microbeam-irradiated fish, massive vascular damage was visible in the mature fin of minibeam-irradiated fish at 
48 hpi. (I,J) Brightfield images of whole caudal fins at 96 hpi.
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the co-localization of both fluorophores in the posterior caudal vein at 5 dpf in vivo. Among all fluorescent cells in 
the blood stream 98.31 ± 0.31% (500 quantified cells from 10 different animals) co-localized, 1.39 ± 0.29% were 
fli1a+/CD41−, and 0.29 ± 0.11% were CD41+/fli1a− (Fig. 2I). These data strongly suggest that thrombocytes and 
neutrophils play early actions in opposing microbeam irradiation-induced damage.
Immature tissue is damaged by both micro- and minibeams. We then asked whether the early cel-
lular response in the immature fin is dependent on the beam width. Therefore, we irradiated semi-amputated 
caudal fins with micro- (25, 50, 100 μ m) and minibeams (200, 400, 800 μ m) with a constant dose of 5000 Gy 
(Fig. 1). Minibeam IR (200, 400, 800 μ m) induced a loss of GFP-signal levels in the beam path, indicating local 
endothelial cell death at 6 hpi (hours post irradiation) in the immature vessels. In the 800 μ m-group, the vascular 
network was discontinuous and displayed isolated endothelial cells (Figs 3F,L and 4D). The damaged tissue was 
infiltrated by neutrophils but we were unable to detect thrombocytes. In contrast to minibeams, microbeams did 
not cause the formation of a prominent gap in the vascular network (Fig. 4B,F). Beamlets of 200 μ m width dis-
rupted arteries and veins (Fig. 3E,K). In the 100 μ m-group, most arteries were found to be discontinuous (SI 4). 
Noteworthy, the damage induced by exposure to microbeams narrower than 100 μ m was restricted to veins. In 
the 25 and 50 μ m-groups, accumulations of fli1a+ cells were observed in the vessel lumen at 6 hpi (Fig. 3B,C,H,I). 
Taken together, thrombocyte adhesion is widely restricted to vessels hit by microbeams whereas minibeams effi-
ciently damage immature tissue.
Mature tissue is damaged by minibeams but not by microbeams. At 6 hpi, the vasculature of the 
mature fin was affected neither by micro- nor by minibeams. At 48 hpi, irradiations with 400 and 800 μ m wide 
beams induced a loss of GFP-signal levels in the beam path, as observed in the immature fin (Fig. 4G). Irradiations 
with 200 μ m wide beams did not induce this effect, suggesting that the width necessary to cause a prominent gap in 
the vascular network lies between 200 and 400 μ m (SI 8/9). At 96 hpi, the entire caudal fins irradiated with 800 μ m 
were irreparably damaged and the necrotic tissue subsequently demarcated (Fig. 4J). Importantly, we did not 
observe any damage caused by microbeam IR in the mature vessels at any time point (Fig. 4A,E).
Minibeams reduce blood perfusion in both mature and immature tissue. To assess blood vessel 
functionality, we determined in vivo blood perfusion distally to the beam path. Few (< 5%) fin rays were found to 
Figure 5. Blood perfusion of the caudal fin following irradiation. (A) Blood perfusion of the mature and 
immature fin at 6 and 48+ hpi (i.e. 48 and 96 hpi) as a functional parameter of blood vessels. At 6 hpi, perfusion 
of the mature fin was unimpaired. Only at later time points, minibeams (400 and 800 μ m) decreased the number 
of perfused fin rays. In contrast, only 25 μ m wide beams did not reduce blood perfusion in the immature fin. 
n = number of animals used for this analysis. Error bars represent standard deviations. P-values of two-tailed 
paired t-tests were considered statistically significant if p < 0.05 (*p < 0.05, **p < 0.01, ***p < 0.001).
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be unperfused in control animals. Blood perfusion was not observed distally to the site of minibeam IR (200, 400, 
800 μ m) in the immature tissue at 6 hpi (Fig. 5B). In contrast to microbeam IR, irradiations with 400 and 800 μ m 
wide beamlets significantly reduced (p = 10−4 (400 μm), p = 5 * 10−5 (800 μm)) or even abolished blood perfusion 
at 48+ hpi in the immature (Fig. 5B), as well as in the mature fin (Fig. 5A).
Microbeams selectively reduce blood perfusion in the immature tissue. Blood perfusion of fins 
irradiated with microbeams (50, 100 μ m width) was significantly reduced in the immature tissue at 6 hpi (Fig. 5B). 
Beam widths of 50 μ m reduced the blood perfusion distally to the beam path to 54.23 ± 3.06% (mean ± SD) and 
100 μ m widths to 13.47 ± 9.52% (Fig. 5B). An illustrative example of an IR of 100 μ m width is shown in the sup-
plementary information (SI 5). This effect can partially be explained by the accumulation of blood cells (mostly 
thrombocytes and neutrophils) in the vessel lumen (Fig. 2A,B) and, more importantly, by the interruption of 
vessels. Exposure to 25 μ m wide microbeams did not affect blood perfusion. At 48 hpi and later, blood perfusion 
was found to be unaffected in all cases, which is most probably due to the zebrafish’s high regenerative capability 
(Fig. 5B). In the mature tissue, we did not observe any significant decrease of blood perfusion after irradia-
tion with microbeams (Fig. 5A). Hence, microbeam IR with 50 and 100 μ m wide beams selectively damaged the 
immature blood vessels and tissue (Fig. 5A,B).
Damage caused to the immature connective tissue. Light and electron microscopy has been per-
formed to visualize the damage caused to the rapidly growing tissue. Control animals display well-visible blood 
vessels lined by endothelial cells and surrounded by a loose connective tissue30 (Fig. 6A–A″ ). At 6 hpi, single cells 
in the path of 50 μ m wide beamlets were characterized by nuclear fragmentations and dense apoptotic bodies in 
electron micrographs (Fig. 6B,B″ ). In the 200 μ m-group, the number of cells containing apoptotic bodies and 
autophagic vacuoles was elevated (Fig. 6C,C″ ). These features are characteristic for cell apoptosis. In addition, tis-
sue macrophages loaded with cell debris were observed (Fig. 6C″ ). In contrast, exposure to 800 μ m wide beamlets 
Figure 6. Structural alteration after micro- and minibeam irradiation. (A–D′) Semithin sections of the 
immature fins stained with toluidine blue. Shown are two neighboring bony fin rays (FR) and the loose 
connective tissue with blood vessels (BV). The site of irradiation is indicated by dashed lines and arrows. The 
cells in the beam path were characterized by solitary dark intracellular bodies and inclusions. Their number 
increased in the path of 200 μ m wide beamlets. (A″ –D″ ) Transmission electron microscopy demonstrated 
normal tissue appearance within the control fins with fibroblasts (F) of normal appearance, embedded in 
loose extracellular matrix and endothelial cells (EC). Electron-dense intracellular apoptotic bodies (ApB). 
Macrophages (Mϕ ) containing cellular debris and autophagic vacuoles (arrowheads). (D) The inter-ray tissue 
was disrupted and infiltrated by neutrophils (Ne).
www.nature.com/scientificreports/
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induced tissue disruption with nuclear and cellular lysates, and the destruction of the plasma membrane leading 
to the disposal of cytoplasmic components and cellular organelles in the extracellular space. The acute cellular 
response is mainly characterized by neutrophils (Fig. 6D,D″ ).
Discussion
We investigated high dose micro- and minibeam IR on mature and immature tissue with an emphasis on the 
vascular damage, cellular toxicity and acute inflammatory response. Microbeam (MRT) and minibeam radiation 
therapies (MBRT) for tumors are approaches of potential clinical relevance, both consisting of parallel X-ray 
beams that allow the delivery of thousands of Grays in their path.
The occurrence of vascular damage in the immature tissue depends on the beam width, which is summarized 
in SI 6. Beams wider than 100 μ m disrupted arteries and veins (Fig. 3 and SI 4). At 48 hpi, these effects were 
no longer visible, which might be due to the regenerative capacity of the zebrafish. The effects of minibeams 
wider than 400 μ m are not restricted to the immature part of the caudal fin and were particularly pronounced at 
48 hpi. This suggests that minibeam IR potentially damages the normal tissue. In contrast, microbeam-irradiation 
induced vascular and tissue damage selectively in the immature vessels and tissue without affecting the mature 
part (Fig. 4).
We demonstrate that microbeams (50 and 100 μ m width) significantly reduce blood perfusion and lead to 
an acute inflammatory response in the immature fin at 6 hpi restricted to the beam path. The immune system of 
zebrafish shows a high degree of overlap with the human system29 and is directly involved (namely macrophages 
and neutrophils) during caudal fin regeneration31. Fli1a is expressed not only in endothelial cells but also in 
certain blood cells of the zebrafish25,32–34. Neutrophil infiltration and the adhesion of fli1a+ blood cells coincided 
locally in the beam path of zebrafish irradiated with 50 μ m-wide beams at 6 hpi. Accumulated fli1a+ blood cells 
appeared rounded, smaller than erythrocytes and express neither CD4 nor CD8. Co-localization of CD41/ fli1a+ 
blood cells was investigated in 5 dpf old zebrafish embryos, wherefore the direct translation of the quantified 
values to adult zebrafish has to be done with care. Nonetheless, CD41 and fli1a+ co-localized in 98.31 ± 0.31% 
(n = 10) of the circulating blood cells in vivo. A small proportion of CD41+ cells (10 out of 824 measured cells) 
did not express fli1a (Fig. 2I, movie in SI 7). It was previously shown that fli1a expression increases during throm-
bocyte maturation and that two populations of different fluorescent intensities exist33. Therefore, we hypothesize 
that the latter are either hematopoietic stem cells or, more likely, immature thrombocytes, which did not start to 
express fli1a yet. Taken together, these data strongly suggest an early involvement of thrombocytes and neutro-
phils in counteracting irradiation-induced endothelial cell damage.
In the light of our study, we add a hypothetical interpretation to the shape of the survival curves of intracere-
bral tumor bearing rats exposed to MRT10,16 and MBRT6,22,35,36. Minibeam-irradiated tumor-baring rats generally 
display a high initial survival rate followed by a rapid chute. This effect could be partially explained by a rapid 
tumor growth control, which is followed by substantial delayed toxicity to normal tissues. In contrast, survival 
curves in MRT-studies appear more widespread and decrease gradually.
To conclude, the present study grants novel insights into the effects depending on the beamlet width of colli-
mated synchrotron-generated X-rays. This is the first comparison of microbeam and minibeam IR-induced vas-
cular and tissue damage on different scale levels in vivo. We observed that high-dose beamlets wider than 400 μ m 
may damage mature tissues, indicating a potential risk of such minibeams in tumor treatment. Exposure to 50 μ m 
wide microbeams damages the loose connective tissue and blood vessels only in the immature fin, and leads to the 
recruitment of neutrophils and thrombocytes locally in the beam path.
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